Moreover, literature meta-analysis data show that CD44 is associated with tumor stage (evaluated with the Classification of Malignant Tumors, TNM) and has been suggested to be an independent factor in reduced overall survival, with its expression correlating with worse prognosis in HCC patients [22,23]. The gene discussed is CD44; the disease is cancer.